A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics (the study of the way a drug
enters and leaves the blood and tissues over time) and safety of paliperidone palmitate in
participants with schizophrenia (psychiatric disorder with symptoms of emotional instability,
detachment from reality, often with delusions and hallucinations, and withdrawal into the
self).